$NNBR

NN, Inc. stock rises 8% on firearms manufacturing contract win By Investing.com

NN, Inc. (NASDAQ:NNBR) shares rose about 8% after the company said it won multi-year contract manufacturing agreements to produce firearms components for a leading U.S. firearms provider. NN expects $12 million to $15 million in sales starting Q3, ramping through 2028. NN plans to update 2026 guidance with Q2 results Aug. 6; Craig-Hallum initiated Buy with a $7.00 target.

Original reporting
Published Jul 20, 2026, 12:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 20, 2026, 12:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$NNBR
Bullish
medium confidence
Mentioned
$NNBR
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$NNBRBullishMed
01

Why it matters

The disclosed multi-year firearms components manufacturing agreements provide quantified expected sales and a clear ramp window, which can re-rate near-term growth expectations until the Aug 6 guidance update.

02

Market read

A same-day contract win with quantified sales expectations and a scheduled guidance update creates a tradable catalyst into the next earnings cycle.

03

What to watch

Key sensitivities are execution risk in titanium machining, laser welding, and surface treatments, plus how much of the contract value translates into adjusted EBITDA versus pass-through costs.

Relevance 8/10Novelty 7/10Timing: Ahead of the Aug 6 second-quarter results where 2026 guidance will be updated.

Background

NN, Inc. is positioning its Defense & Electronics segment around ITAR-compliant contract manufacturing and compliance programs for defense-market customers.

Company-level read

Ticker impact

$NNBRBullishMedium confidence
Context

NN, Inc. shares rose 8% after announcing multi-year contract manufacturing agreements to produce firearms components, with $12M-$15M expected sales starting Q3.

Expected impact

Near-term upside bias with follow-through risk if Q2 guidance update or ramp assumptions disappoint.

Evidence & confidence

The article provides contract scope, expected sales ($12M-$15M), start timing (Q3), and ramp through 2028, plus a stated plan to update 2026 guidance on Aug 6.

Market effects

Reinforces demand for defense-related precision manufacturing and compliance-driven contract manufacturing capabilities (ATF/FFL/ITAR/CMMC).

Highlights U.S.-based ITAR-compliant production capacity, which can matter for domestic defense supply chains.

Limited, as the contracts are tied to a leading U.S. firearms provider and U.S. compliance regimes.

Counterpoint

The revenue contribution ($12M-$15M) may be modest versus the company’s broader base, so the stock’s 8% move could overshoot if margins or ramp timing are less favorable.

Key entities

  • NN, Inc.

    Precision components manufacturer that announced multi-year firearms components contract manufacturing agreements.

  • Harold Bevis

    CEO who commented on the payoff from investments and collaborative innovation with the brand owner.

  • ATF/FFL/ITAR/CMMC

    Compliance regimes referenced as part of NN’s ability to serve the defense market.

Related articles

$NNBRHighAI 9/10

NN INC (NNBR): Results of Operations and Financial Condition

NN INC (NNBR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pressrelease2026-q2.htm EX-99.1 PRESS RELEASE Document FOR IMMEDIATE RELEASE NN, INC. REPORTS SECOND QUARTER 2026 RESULTS NN Delivers Strong Second Quarter, Raises Outlook for 2026, Announces Refinancing 5 Pillar Growth Program Delivering Above Expectations; Data Center

$NNBRMedAI 8/10

NN (NNBR) Shares Skyrocket, What You Need To Know

NN (NASDAQ: NNBR) shares rose 11.9% after the company said it entered firearms components manufacturing via contract agreements with a leading U.S. provider. NN expects $12 million to $15 million in added sales starting in Q3, ramping through 2028, as part of a Defense and Electronics plan to reach $100 million sales in five years.

$NNBRMed

NN (NNBR) Stock Trades Up, Here Is Why

NN (NASDAQ: NNBR) shares rose about 5.6% after the company received initial purchase orders to supply components for a robotic-assisted surgery platform, following a full-facility audit at its Kentwood, Michigan plant. NN said the orders should add ~$25M to its medical new-business pipeline (to ~$75M) within a >$750M total pipeline. Stock later traded around $3.61 (+4.4%).

$NNBRMedAI 8/10

Why NN (NNBR) Stock Is Trading Lower Today

NN (NNBR) shares fell 13.9% after the company announced a $75 million private placement of common stock. NN agreed to sell 24,509,804 shares to institutional investors at $3.06 per share, increasing share count and diluting existing holders. The deal is expected to close subject to customary conditions.